Your browser doesn't support javascript.
COVID-19 Case Investigation and Contact Tracing in the US, 2020.
Lash, R Ryan; Moonan, Patrick K; Byers, Brittany L; Bonacci, Robert A; Bonner, Kimberly E; Donahue, Matthew; Donovan, Catherine V; Grome, Heather N; Janssen, Julia M; Magleby, Reed; McLaughlin, Heather P; Miller, James S; Pratt, Caroline Q; Steinberg, Jonathan; Varela, Kate; Anschuetz, Greta L; Cieslak, Paul R; Fialkowski, Veronica; Fleischauer, Aaron T; Goddard, Clay; Johnson, Sara Jo; Morris, Michelle; Moses, Jill; Newman, Allison; Prinzing, Lauren; Sulka, Alana C; Va, Puthiery; Willis, Matthew; Oeltmann, John E.
  • Lash RR; Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, Georgia.
  • Moonan PK; COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia.
  • Byers BL; COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia.
  • Bonacci RA; COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia.
  • Bonner KE; Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, Georgia.
  • Donahue M; Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, Georgia.
  • Donovan CV; Public Health Division, Oregon Health Authority, Portland.
  • Grome HN; Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, Georgia.
  • Janssen JM; Nebraska Department of Health and Human Services, Lincoln.
  • Magleby R; Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, Georgia.
  • McLaughlin HP; North Carolina Department of Health and Human Services, Raleigh.
  • Miller JS; Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, Georgia.
  • Pratt CQ; Tennessee Department of Health, Nashville.
  • Steinberg J; Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, Georgia.
  • Varela K; Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, Georgia.
  • Anschuetz GL; New Jersey Department of Health, Trenton.
  • Cieslak PR; COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia.
  • Fialkowski V; Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, Georgia.
  • Fleischauer AT; Washington State Department of Health, Tumwater.
  • Goddard C; Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, Georgia.
  • Johnson SJ; Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, Georgia.
  • Morris M; South Dakota State Health Department, Sioux Falls.
  • Moses J; Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, Georgia.
  • Newman A; New Jersey Department of Health, Trenton.
  • Prinzing L; Public Health Division, Oregon Health Authority, Portland.
  • Sulka AC; Vermont Department of Health, Burlington.
  • Va P; North Carolina Department of Health and Human Services, Raleigh.
  • Willis M; Career Epidemiology Field Officer Program, Centers for Disease Control and Prevention, Atlanta, Georgia.
  • Oeltmann JE; Springfield-Greene County Health Department, Springfield, Missouri.
JAMA Netw Open ; 4(6): e2115850, 2021 06 01.
Article in English | MEDLINE | ID: covidwho-1251884
ABSTRACT
Importance Contact tracing is a multistep process to limit SARS-CoV-2 transmission. Gaps in the process result in missed opportunities to prevent COVID-19.

Objective:

To quantify proportions of cases and their contacts reached by public health authorities and the amount of time needed to reach them and to compare the risk of a positive COVID-19 test result between contacts and the general public during 4-week assessment periods. Design, Setting, and

Participants:

This cross-sectional study took place at 13 health departments and 1 Indian Health Service Unit in 11 states and 1 tribal nation. Participants included all individuals with laboratory-confirmed COVID-19 and their named contacts. Local COVID-19 surveillance data were used to determine the numbers of persons reported to have laboratory-confirmed COVID-19 who were interviewed and named contacts between June and October 2020. Main Outcomes and

Measures:

For contacts, the numbers who were identified, notified of their exposure, and agreed to monitoring were calculated. The median time from index case specimen collection to contact notification was calculated, as were numbers of named contacts subsequently notified of their exposure and monitored. The prevalence of a positive SARS-CoV-2 test among named and tested contacts was compared with that jurisdiction's general population during the same 4 weeks.

Results:

The total number of cases reported was 74 185. Of these, 43 931 (59%) were interviewed, and 24 705 (33%) named any contacts. Among the 74 839 named contacts, 53 314 (71%) were notified of their exposure, and 34 345 (46%) agreed to monitoring. A mean of 0.7 contacts were reached by telephone by public health authorities, and only 0.5 contacts per case were monitored. In general, health departments reporting large case counts during the assessment (≥5000) conducted smaller proportions of case interviews and contact notifications. In 9 locations, the median time from specimen collection to contact notification was 6 days or less. In 6 of 8 locations with population comparison data, positive test prevalence was higher among named contacts than the general population. Conclusions and Relevance In this cross-sectional study of US local COVID-19 surveillance data, testing named contacts was a high-yield activity for case finding. However, this assessment suggests that contact tracing had suboptimal impact on SARS-CoV-2 transmission, largely because 2 of 3 cases were either not reached for interview or named no contacts when interviewed. These findings are relevant to decisions regarding the allocation of public health resources among the various prevention strategies and for the prioritization of case investigations and contact tracing efforts.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: Public Health / Contact Tracing / COVID-19 Type of study: Diagnostic study / Observational study / Prognostic study / Randomized controlled trials Topics: Long Covid Limits: Humans Country/Region as subject: North America Language: English Journal: JAMA Netw Open Year: 2021 Document Type: Article Affiliation country: Jamanetworkopen.2021.15850

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Public Health / Contact Tracing / COVID-19 Type of study: Diagnostic study / Observational study / Prognostic study / Randomized controlled trials Topics: Long Covid Limits: Humans Country/Region as subject: North America Language: English Journal: JAMA Netw Open Year: 2021 Document Type: Article Affiliation country: Jamanetworkopen.2021.15850